Skip to content

Therapeutic effect of thumbtack needle in the treatment of allergic rhinitis and its immune regulation of ILC-2 cells: a randomized controlled trial

Therapeutic effect of thumbtack needle in the treatment of allergic rhinitis and its immune regulation of ILC-2 cells: a randomized controlled trial

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1900023740
Enrollment
Unknown
Registered
2019-06-10
Start date
2019-06-14
Completion date
Unknown
Last updated
2019-06-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Allergic rhinitis

Interventions

Sponsors

Guangdong Provincial Hospital of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1 Meet the allergic rhinitis Chinese and western diagnostic criteria. 2 Aged 18 to 65 years, gender is not limited. 3 Sign the informed consent form and volunteer to participate in the study. 4 Participants can fill in the case report form and follow-up form by themselves.

Exclusion criteria

Exclusion criteria: 1 Acute rhinitis (cold), vasomotor rhinitis, autonomic rhinitis, eosinophilic non-allergic rhinitis, allergic sinusitis. 2 Tape allergy history. 3 Local skin lesions such as burns, eczema, ulcers, frostbite ulceration. 4 During pregnancy and intent to pregnant women. 5 Due to intellectual or behavioral disorders, the test and investigators cannot be fully matched. 6 Participants who are lost to follow-up due to frequent changes in the working environment.

Design outcomes

Primary

MeasureTime frame
nasal symptom score;

Secondary

MeasureTime frame
Changes in cytokines IL-33, IL-25 and TSLP;Visual simulation score sheet (10 points);Rhinoconjunctivitis Quality of Life Questionnaire (Standard Edition);Drug usage record;Allergic rhinitis medical expenses;

Countries

China

Contacts

Public ContactJiyan Xia

Guangdong Provincial Hospital of Chinese Medicine

13725229838@163.com+86 13725229838

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026